GlassScriptPhysician profile
Sarat Meka
NPI 1952560765
$9,212.02
in general payments reported to CMS, 2019-2025
37 companies · $1,467 in 2025
The $1,467 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,341 · 2020: $1,110 · 2021: $1,566 · 2022: $1,191 · 2023: $1,371 · 2024: $1,165 · 2025: $1,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,003.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,329.54 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $1,917.09 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $1,233.25 | 2019-2025 | |
| Amgen INC. | $602.39 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $362.62 | 2019-2025 | Zepbound, Mounjaro, Emgality |
| Amarin Pharma, INC. | $267.16 | 2019-2021 | |
| Inspire Medical Systems, INC. | $255.41 | 2023-2025 | Inspire |
| Janssen Pharmaceuticals, INC | $206.06 | 2020-2021 | |
| Allergan, INC. | $189.38 | 2019-2020 | |
| Exact Sciences Corporation | $188.97 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $164.70 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.75 | 2021-2025 | |
| Abbott Laboratories | $144.97 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Cerapedics INC. | $140.34 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Novo Nordisk INC | $130.63 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarat Meka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.